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Expression of a soluble CD4 molecule (sCD4-KDEL) containing a specific retention signal for the endoplasmic reticulum
was shown previously to block propagation of the HIV-1MN prototype strain in a transformed T cell line. However, the virus
present in HIV-1-infected individuals is more closely represented by primary HIV-1 isolates which, unlike the HIV-1MN strain,
have not been adapted to growth in cell lines. To determine if sCD4-KDEL could block replication of primary isolates we
used the PM1 cell line that has been shown to propagate primary isolates without adaptation. Here we show that the
replication of four primary HIV-1 isolates was strongly inhibited in PM1 cells that expressed sCD4-KDEL under control of
the HIV-1 LTR. Infection with primary HIV-1 isolates induced sCD4-KDEL expression driven by the LTR, HIV-1 spread was
dramatically reduced, and reverse transcriptase activity in the cell culture supernatants was greatly diminished. sCD4-KDEL,
therefore, represents a potent inhibitor of HIV-1 replication for gene therapy-based approaches for the treatment of AIDS.
q 1996 Academic Press, Inc.
Gene therapy offers a promising approach for the treat- the HIV-1 long terminal repeat (LTR). In H9 cells trans-
duced with this vector, only a very low level of sCD4-ment of the acquired immunodeficiency syndrome (AIDS)
(for discussion and review of strategies see Baltimore, KDEL is expressed. Following infection of the cells with
HIV-1, expression of the HIV Tat protein transactivates1988; Pomerantz and Trono, 1995) The basic scheme
envisioned is that genes encoding RNAs or proteins that the LTR and induces high level expression of sCD4-KDEL
(Buonocore and Rose, 1993). This high level expressiondominantly interfere with HIV-1 replication would be in-
troduced into the hematopoietic stem cells of HIV-1-in- of sCD4-KDEL completely blocks propagation of the HIV-
1 prototype strain MN. Following the initial infection, p24fected individuals. After reintroduction of these cells into
patients, the transduced stem cell progeny, which in- is released into the culture medium, but no infectious
HIV particles are released, the infection does not spread,clude CD4/ lymphocytes and cells of the monocyte/mac-
rophage lineage, would then express the transduced and after 4 to 6 weeks the cells infected initially can no
longer be detected in the culture. In addition, no syncy-genes and inhibit the replication of HIV-1. Although tech-
niques are not yet available to obtain efficient repopula- tium formation was observed, as would be expected if
gp160 transport were blocked in the ER. This approachtion of humans with genetically modified stem cells, re-
cent work has established that transfection of CD4/ pe- to inhibiting the spread of HIV-1 infection is particularly
attractive because HIV-1 should not be able to avoid theripheral blood lymphocytes with a gene inhibiting HIV
replication can prolong survival of these cells after intro- block through mutations in gp120 that would block CD4
binding. Although such mutants could occur, they wouldduction into HIV-1-infected persons (Woffendin et al.,
1996). These results provide encouragement for continu- no longer be capable of infection via CD4.
HIV-1MN and other HIV-1 isolates that have been exten-ing studies on means for inhibiting HIV replication.
We have previously reported that sCD4-KDEL, a solu- sively passaged in and adapted to growth in transformed
T-cell lines are commonly referred to as ‘‘laboratory’’ HIV-ble CD4 molecule that is retained in the endoplasmic
reticulum (ER) by the retention signal Lys-Asp-Glu-Leu 1 isolates. Such isolates have been found to differ signifi-
cantly from ‘‘primary’’ HIV-1 isolates which have been(K-D-E-L) (Munro and Pelham, 1987), effectively binds to
and retains HIV-1 gp160 in the ER (Buonocore and Rose, minimally passaged only in peripheral blood mononu-
clear cells (PBMCs). Many primary isolates cannot be1990). We have also described a retroviral vector, LHSN/
sCD4-KDEL that encodes sCD4-KDEL under control of propagated initially in transformed T-cell lines (Asjo et
al., 1986) and must be passaged extensively before they
become adapted. This adaptation has been correlated1 Deceased, see Acknowledgments.
with mutations of the viral envelope protein and alter-2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (203) 785-7467. ations of viral phenotype (Harrowe and Cheng-Mayer,
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1995; Moore et al., 1993; Orloff et al., 1995; Wang et al.,
1995; Wrin et al., 1995). As a result of these mutations,
laboratory isolates have an abnormal sensitivity to neu-
tralization by sera obtained from HIV-1-infected individu-
als (Moore et al., 1995). Moreover, laboratory isolates are
100 to 1000 times more sensitive to neutralization by
recombinant soluble CD4 (sCD4), compared to primary
HIV-1 isolates (Daar et al., 1990). However, the de-
creased sensitivity of primary HIV-1 isolates to neutraliza-
tion by sCD4 does not appear to be related to a de-
creased affinity of HIV-1 envelope protein for CD4 (Ash-
kenazi et al., 1991; Turner et al., 1992). Rather, structural
alterations of the oligomeric envelope protein complex
displayed on the HIV-1 virion surface appear to be re-
sponsible for the different phenotypes of laboratory and
primary HIV-1 isolates (Moore et al., 1992).
Because gp160 molecules from primary and labora-
tory isolates differ, and since primary isolates are more
likely to reflect the virus present in HIV-1-infected indi-
viduals (Moore et al., 1995), we felt it was important
to determine whether the replication of primary HIV-1
isolates would be inhibited in cells transduced with a
retroviral vector that encodes sCD4-KDEL. This was
also especially important because of the requirement
of high concentration of sCD4 for neutralization of pri-
mary isolates (Daar et al., 1990).
PM1 cells, a human T-cell line which has a unique
susceptibility to infection by primary HIV-1 isolates
(Lusso et al., 1995), were transduced with the recombi-
nant retroviral vectors LHSN and LHSN/sCD4-KDEL (Bu-
onocore and Rose, 1993) by incubating the cells with
supernatants of PA317 cell clones that produced the re-
combinant vectors. The PM1 cells were then cultured in
complete medium with 1.5 mg/ml G418 (Gibco) and
G418-resistant PM1 cell pools were cloned by limiting
FIG. 1. Inhibition of syncytium formation in a LHSN/sCD4-KDEL-
dilution. transduced PM1 cell clone. LHSN-transduced PM1 cells or LHSN/
To determine initially if functional sCD4-KDEL was be- sCD4-KDEL-transduced PM1 cells were infected with HIV-1IIIB , cultured
for 1 week, and observed by light microscopy. (A) Syncytium formationing expressed in the PM1 cell line, individual clones were
in a PM1 cell clone transduced with the control LHSN vector. (B) Lackchallenged with the laboratory isolate HIV-1IIIB . At 1 week
of syncytium formation in a PM1 cell clone transduced with LHSN/postinfection, 5 of 16 of the LHSN/sCD4-KDEL trans-
sCD4-KDEL.
duced PM1 cell clones showed a complete protection
from HIV-1IIIB-induced syncytium formation (Fig. 1). This
result suggested that these five clones expressed suffi- herz et al., 1979). Secondary antibodies were FITC-conju-
gated anti-human IgG (Murex) and rhodamine conju-cient sCD4-KDEL to retain the HIV-1IIIB gp160 in the ER.
In contrast, all subclones of LHSN-transduced PM1 cells gated anti-mouse IgG (Jackson Immunoresearch). The
cells were then observed with a Nikon Microphot-FX mi-showed syncytium formation when infected with HIV-1IIIB .
To assay for sCD4-KDEL production, HIV-1-infected croscope.
HIV-1-positive cells were found in the cultures of thePM1 cell clones were fixed (McLean and Nakane, 1974)
and permeabilized with 0.1% Triton X-100 and then ana- five PM1 clones that did not form syncytia, and as ob-
served previously in H9 cells (Buonocore and Rose, 1993)lyzed by indirect immunofluorescence for the presence
of HIV-1 antigens and sCD4-KDEL. The cells were every HIV-1-positive cell examined also expressed high
levels of sCD4-KDEL. In contrast, LHSN-transduced con-washed and resuspended in a 1:100 dilution of HIVIG
(Prince et al., 1988) a purified immunoglobulin reactive trol cells infected with HIV-1IIIB showed only HIV-1-posi-
tive staining and no sCD4-KDEL staining (data notwith HIV-1 structural proteins (obtained through the AIDS
Research and Reference Reagent Program, ARRRP), and shown).
To determine if the replication of primary HIV-1 isolatesa 1:100 dilution of OKT4 ascites, reactive with CD4 (Rein-
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FIG. 2. Detection of HIV-1 antigens and sCD4-KDEL in HIV-1-infected cells by immunofluorescence microscopy. An LHSN-transduced PM1 cell
clone was infected with HIV-1301657 . At 2 weeks postinfection a typical field showed many cells staining positively for HIV-1 antigens (A). The same
cells showed only background staining for sCD4 (B). At 2 weeks postinfection the LHSN/sCD4-KDEL transduced PM1 cell clone showed very few
HIV-1301657-positive cells (C). Every HIV-1-positive cell also showed a strong cytoplasmic staining for sCD4-KDEL (D).
was inhibited in PM1 cell clones that expressed sCD4- infected with HIV-1301657 and HIV-1302151 appeared as mul-
tinucleated syncytia. The cells exhibited a strong cyto-KDEL, four different primary isolates of HIV-1 (obtained
through the ARRRP) were used to infect a LHSN/sCD4- plasmic and surface staining for HIV-1 proteins com-
pared to uninfected control cells, and only a diffuse back-KDEL-transduced PM1 clone as well as an LHSN-trans-
duced control PM1 cell clone. The HIV-1 isolates in- ground CD4 staining (Figs. 2A and 2B). Note that
endogenous CD4 is expressed at only very low levelscluded HIV-1Ba-L , a macrophage tropic, nonsyncytium in-
ducing (NSI) isolate, HIV-1301657 , a syncytium inducing and is undetectable by immunofluorescence. In contrast,
only a small number of HIV-1-infected, LHSN/sCD4-(SI) isolate, HIV-1302056 , and HIV-1302151 , an SI infant iso-
late. The PM1 cells were challenged with the HIV-1 iso- KDEL-transduced PM1 cells were found but every HIV-
1-positive cell found showed a strong ER staining patternlates at a multiplicity of infection (m.o.i.) of 0.02 to 0.06
infectious particles per cell. Using an immunofluores- for sCD4-KDEL (Figs. 2C and 2D). This strong staining
pattern indicated the expression and ER retention ofcence assay for both HIV-1 and sCD4-KDEL at 4 days
postinfection, we found that the LHSN vector transduced sCD4-KDEL as previously described (Buonocore and
Rose, 1990; Buonocore and Rose, 1993).PM1 cells and the sCD4-KDEL expressing cells were
equally infected at low levels by all four primary isolates The numbers of HIV-1-infected, LHSN-transduced, and
LHSN/CD4-KDEL-transduced PM1 cells were then quan-(data not shown). To determine if the spread of infection
was inhibited by sCD4-KDEL as observed previously with titated at 2 weeks postinfection (Fig. 3A). At 2 weeks
postinfection, approximately 30% of LHSN control cellsthe HIV-1MN strain, we analyzed infection and sCD4-KDEL
expression by indirect immunofluorescence at 2 weeks were infected with HIV-1Ba-L while 100% of the cells were
infected with HIV-1301657 . The levels of infection of controland 6 weeks postinfection (Fig. 2).
In the control, LHSN-transduced PM1 cells, HIV-1-in- cells with HIV-1302056 and HIV-1302151 were 0.8 and 20%,
respectively. In contrast, in the LHSN/sCD4-KDEL-trans-fected cells were observed in the cultures of all four
viral isolates at 2 weeks postinfection. Many of the cells duced cells, HIV-1-infected cells were either no longer
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detectable (HIV-1302056 and HIV-1302151) or there were 100-
to 1000-fold fewer HIV-1-positive cells compared with
LHSN-transduced cells (HIV-1Ba-L and HIV-1301657). The
loss of HIV-1-infected cells in the sCD4-KDEL transduced
lines was seen previously in H9 cells infected with HIV-
1MN . Infected cells are eliminated from infected cultures,
either because they grow more slowly than uninfected
cells or are eventually killed by the infection (Buonocore
and Rose, 1993).
At 6 weeks postinfection, the number of LHSN control
cells infected with HIV-1Ba-L did not change significantly.
However, we did observe an increase from 0.2 to 1.5%
in the PM1 cells expressing sCD4-KDEL. In addition,
there was a more significant increase from 0.2 to 10% in
the HIV-1301657-infected cells. These data suggest that a
low level of infectious virus is being released from sCD4-
KDEL expressing cells infected with these two isolates,
presumably because a low level of gp160 is able to es-
cape the sCD4-KDEL trap.
To follow the kinetics of primary HIV-1 infection in
LHSN-transduced and LHSN/sCD4-KDEL-transduced
FIG. 4. Reverse transcriptase assay of supernatants of LHSN control-
transduced or LHSN/sCD4-KDEL-transduced PM1 cells. Cells were
infected with HIV-1Ba-L (A) and HIV-1301657 (B) and supernatants assayed
for reverse transcriptase at the indicated times postinfection. Back-
ground counts were subtracted from all samples. The drop in RT activity
in the control cells corresponded with a severe cytopathic effect of the
infection and a temporary drop in cell numbers.
PM1 cells we also used a reverse transcriptase (RT)
assay performed essentially as described (Hoffman et
al., 1985), using supernatants of the HIV-1-infected cell
cultures. Both HIV-1Ba-L and HIV-1301657 productively in-
fected LHSN-PM1 cells as shown by a rapid peak in
culture supernatant RT activity (Figs. 4A and 4B). The
rapid loss of RT activity at later time points was due to
extensive cell death in the infected cultures. In contrast,
only background RT activity was detected in the superna-
tants of HIV-1Ba-L or HIV-1301657-infected, LHSN/sCD4-
KDEL-transduced PM1 cells, for up to 3 weeks in culture.
The supernatant of HIV-1301657-infected, LHSN/sCD4-
KDEL-transduced PM1 cells did eventually show a low
but significant RT activity at 21 days postinfection. This
small amount of RT activity is consistent with the spread
of HIV-1301657 observed in LHSN/sCD4-KDEL-transducedFIG. 3. Percentage of HIV-1-infected cells determined by immunofluo-
cells at 6 weeks postinfection (see Fig. 3B). Collectively,rescence microscopy. The percentage of infected cells was determined
at 2 weeks (A) and 6 weeks (B) postinfection. these data suggest that HIV-1301657-infected, LHSN/sCD4-
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even in the face of illness. Steve inspired all who knew him. This workKDEL-transduced PM1 cells can produce a low level of
was supported by Grant RO1-AI30374 from the National Institutes ofinfectious virus.
Health.
The retention of HIV-1 gp160 in the ER by sCD4-KDEL
prevents cleavage to gp120/gp41 and its subsequent ex-
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